Patents Assigned to HZNP LIMITED
  • Diclofenac topical formulation
    Patent number: 9220784
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: December 29, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9168305
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: October 27, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9168304
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: October 27, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • Treatment of pain with topical diclofenac
    Patent number: 9132110
    Abstract: The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: September 15, 2015
    Assignee: HZNP LIMITED
    Inventors: Jagat Singh, Joseph Zev Shainhouse, Bradley S. Galer, Robert Dominic King-Smith, Lisa Marie Grierson, Maria Burian, Jonathan Wilkin, Edward Kisak, John M. Newsam
  • Diclofenac topical formulation
    Patent number: 9101591
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: January 14, 2015
    Date of Patent: August 11, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9066913
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: June 30, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh